Local Production

Egypt’s Ministry of Health and Population announced that the state-owned Holding Company for Biological Products and Vaccines (VACSERA) hosted a delegation from GenVax Egypt and China’s Minhai to accelerate efforts in localizing production of a key childhood vaccine. The visit aims to fast-track a “gap analysis” plan needed to activate an existing agreement between VACSERA and GenVax Egypt for domestic manufacturing of the pneumococcal conjugate vaccine (PCV13).